176 related articles for article (PubMed ID: 36268854)
21. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
22. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 vaccination simulating lymph node progression in a patient with prostate cancer.
Andresciani F; Ricci M; Grasso RF; Zobel BB; Quattrocchi CC
Radiol Case Rep; 2022 Sep; 17(9):2996-2999. PubMed ID: 35747740
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT.
Ahmed N; Muzaffar S; Binns C; Ilyas MW; Usmani S
Clin Nucl Med; 2021 May; 46(5):435-436. PubMed ID: 33661193
[TBL] [Abstract][Full Text] [Related]
26.
Peacock JG; Banks EA; McWhorter N
J Nucl Med Technol; 2022 Mar; 50(1):73-74. PubMed ID: 34872921
[TBL] [Abstract][Full Text] [Related]
27. Discordant results in
Parisse-Di Martino S; Faure C; Mognetti T
Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
[TBL] [Abstract][Full Text] [Related]
29. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Vaccination with Pfizer-BioNTech or CoronaVac on Disease Prognosis Among Hospitalized COVID-19 Patients.
Güldan M; Ateş ST; Sarıoğlu S; Suyabatmaz S; İrkören P; Tekin S; Kapmaz M; Keske Ş; Ergönül Ö
Infect Dis Clin Microbiol; 2023 Jun; 5(2):106-112. PubMed ID: 38633010
[TBL] [Abstract][Full Text] [Related]
31. [
Nogami M; Tsujikawa T; Maeda H; Kosaka N; Takahashi M; Kinoshita N; Mori T; Makino A; Kiyono Y; Murakami T; Goi T; Okazawa H
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296702
[TBL] [Abstract][Full Text] [Related]
32. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
33. Generalized Lymph Node Activation after Influenza Vaccination on
Ayati N; Jesudason S; Berlangieri SU; Scott AM
Asia Ocean J Nucl Med Biol; 2017; 5(2):148-150. PubMed ID: 28660226
[TBL] [Abstract][Full Text] [Related]
34. Increased
Otomi Y; Irahara S; Inoue H; Shinya T; Otsuka H; Harada M
Mol Imaging Radionucl Ther; 2022 Jun; 31(2):169-171. PubMed ID: 35771098
[TBL] [Abstract][Full Text] [Related]
35. Axillary Adenopathy Secondary to SARS-CoV-2 Vaccination: a Case Report.
Koff A; Inaty H
SN Compr Clin Med; 2022; 4(1):61. PubMed ID: 35224447
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer.
Simsek M; Yasin AI; Besiroglu M; Topcu A; Sucuoglu Isleyen Z; Seker M; Turk HM
J Med Virol; 2022 Sep; 94(9):4138-4143. PubMed ID: 35513241
[TBL] [Abstract][Full Text] [Related]
39. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
[TBL] [Abstract][Full Text] [Related]
40. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
